Key Highlights
•
Specific combinations of proteins in the blood can accurately predict the location of Alzheimer’s-related damage in the brain and future memory decline. This finding means a simple blood test could become a cost-effective and non-invasive tool for early detection and monitoring of Alzheimer’s disease.
Source →
•
A systematic review found that a documented plan to reduce opioid use is strongly linked to successful dose reduction in patients with chronic non-cancer pain. This highlights a simple, modifiable step clinicians can take to help patients safely reduce their reliance on these high-risk medications.
Source →
•
Pelvic venous disorders are a significant but often missed cause of chronic pelvic pain in women, requiring collaboration between gynecologists and interventional radiologists for proper diagnosis and treatment. Increasing awareness of this condition can lead to earlier intervention and better outcomes for many women suffering from unexplained pain.
Source →
•
In Barrett’s esophagus surveillance, advanced imaging techniques like narrow band imaging can detect precancerous changes more effectively than standard white light endoscopy. However, these newer methods still cannot completely replace the traditional, more extensive biopsy protocol for ensuring patient safety.
Source →
•
The loss of a specific gene called MTAP is common in certain lung cancers driven by other genetic mutations and may make these tumors more sensitive to a new class of drugs called PRMT5 inhibitors. This discovery opens a potential new treatment pathway for a subset of patients with non-small cell lung cancer.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
